Key Highlights: HTX to refund old Huobi management fees, with 50% returned instantly upon login. Trade-to-unlock model will…
Bitcoin Core v0.30 Must Remain Conservative on Protocol Changes, Michael Saylor Emphasizes Global Consensus
Bitcoin’s demand spell that began just over a year ago has cooled off, and market indicators suggest the crypto may be entering a bear phase, according to sentiment analysis from CryptoQuant. The analytics and chart platform has noted that while Bitcoin is still one of the world’s most traded digital assets, its momentum is waning, and accumulation rates from retailers and institutions pattern shift have dropped to 12-month lows. Institutional demand contracts amid ETF sell-offs The Bitcoin institutional players who were more than welcoming to the Donald Trump administration at the start of the year have made the end of 2025 a crypto investment ghost town. Bitcoin’s demand boom is fading. This cycle ran on three spot demand waves, and the latest one looks like it’s rolling over. Since early October, demand is below trend, which can stay bearish for price. pic.twitter.com/7IWnRscD8H — CryptoQuant.com (@cryptoquant_com) December 19, 2025 According to CryptoQuant’s analysis , US spot Bitcoin ETFs in the fourth quarter of 2025 shifted from net buyers to net sellers, shedding approximately 24,000 BTC. The addresses holding between 100 and 1,000 BTC, which are mostly ETFs and treasury companies , have been expanding at below-trend rates. CryptoQuant’s analysts believe these conditions are very similar to the end of 2021 when it clocked an all-time high of $69K in November, then fell to almost half its price in January 2022 bear market. Bitcoin ETFs attracted net inflows of $457 million on Thursday, the third-largest single-day inflow since early October. Previous peaks were recorded on November 11 and October 21, with inflows of $523.98 million and $477.19 million, respectively, according to SoSoValue data. However, the month of December had witnessed redemptions of $100 million from these vehicles before the Thursday overhaul. If inflows do not accelerate in the second half of the month, we might be in for another “dark November” that featured $3.7 billion outflows. Derivative markets spell reduced risk appetite CryptoQuant noted that declining funding rates could indicate a reduced willingness among traders to hold onto their long positions, which typically occurs during bear market cycles. Coinglass says that Bitcoin and Ether’s volatility smiles are skewed toward out-of-the-money put options at all tenors. This shows that traders still want protection against losses. Short-dated volatility may have eased from earlier extremes that pulled BTC down to $80,000. However, the overall price movement is more bearish than bullish, which could mean the market is not expecting a positive run heading into 2026. Analyst IT Tech wrote that short-term holders of Bitcoin are sitting on average losses of -14.9%, with the crypto currently trading at $86,700 while their average cost basis is around $101,800. This, per the market watcher, has created a “pain zone,” where attempts by the market to rebound toward $101,000 could cause panic selling and profit taking. Bitcoin’s price has also fallen below its 365-day moving average, the long-term technical support that distinguishes bull from bear markets. And as several chartists on X have insinuated, demand cycles drive Bitcoin’s four-year market behavior more than halving events do. Despite these signals, historical bear market bottoms for Bitcoin appear on the heels of the king coin’s realized price, currently near $56,000 and 55% from recent all-time highs. The crypto’s intermediate support is currently around $70,000, but if BTC drops below that threshold, investors might as well wait for a $50,000 flash alert. The crypto market has declined about 13% year-to-date, with Bitcoin down 10% over the same period. The total market capitalization has dipped below $3 trillion, its lowest point since April. Still, some crypto enthusiasts are urging the community not to forget the years of exceptional growth the market has experienced. “I get that this year is a drag, but consider Bitcoin was up 468% in the two years prior. That’s an annual return of 138%, eight times more than US stocks. It’s like your ice cream sundae now has 55 cherries instead of 60. You’re fine!” argued Bloomberg senior ETF analyst Eric Balchunas. If you're reading this, you’re already ahead. Stay there with our newsletter .
Malaysia’s RMJDT shows how Asia is pulling stablecoins into regulated finance, linking tokenized assets with local-currency onchain settlement.
Bitcoin’s 36% drawdown from its all-time highs resulted in the relative strength index flashing a potential bottom signal not seen since early 2023.
Nasdaq-Listed Mangoceuticals Partners with Cube Group to Build $1B SOL Crypto Treasury via Mango DAT; Files MULTI-DAT Trademark
Hyperliquid (HYPE) shows high volatility, attracting significant investor attention. Current price trends suggest potential equilibrium, with analysts noting critical thresholds. Continue Reading: Hyperliquid Sparks Investor Interest with Recent Performance Surge The post Hyperliquid Sparks Investor Interest with Recent Performance Surge appeared first on COINTURK NEWS .
BitcoinWorld Strategic SOL Investment: Nasdaq Giant Mangoceuticals Allocates $100M to Solana Treasury In a bold move that underscores the growing institutional embrace of cryptocurrency, Nasdaq-listed healthcare firm Mangoceuticals has announced a groundbreaking SOL investment strategy. The company plans to deploy up to $100 million into Solana’s native token, SOL, through a newly established Digital Asset Treasury. This decision marks a significant pivot for a traditional healthcare company and signals deepening confidence in blockchain technology’s financial infrastructure. Why Is This SOL Investment a Major Signal for Crypto Markets? Mangoceuticals isn’t just dipping a toe in the water; it’s making a strategic, nine-figure commitment. The creation of a dedicated subsidiary, Mango DAT (Digital Asset Treasury), formalizes this SOL investment as a core part of its corporate strategy. To manage this substantial treasury, the company has partnered with Cube Group, led by a former Solana core developer, ensuring expert custody and strategic asset management. This move demonstrates that serious institutional players are now looking beyond Bitcoin and Ethereum, seeking growth and utility in high-performance layer-1 networks like Solana. Beyond the SOL Investment: A Multi-Pronged Digital Asset Strategy Mangoceuticals’ vision extends far beyond a simple token purchase. The company’s SOL investment is the cornerstone of a broader digital transformation plan. Their strategy includes several key initiatives designed to generate value and integrate blockchain across operations: Tokenization of Real World Assets (RWAs): Exploring how to represent physical assets, like intellectual property or equipment, on the blockchain. Staking and Node Operations: Actively participating in the Solana network to earn rewards and support its security and decentralization. Stablecoin Adoption: Implementing stablecoins for corporate payments and settlements to increase efficiency and reduce transaction costs. This holistic approach shows a deep understanding of how to leverage crypto assets for both treasury growth and operational improvement. What Does This Mean for Institutional Crypto Adoption? The announcement is a powerful validation for the entire cryptocurrency sector. When a publicly-traded company on a major exchange like Nasdaq makes such a definitive SOL investment , it sends a clear message to other corporations. It demonstrates that digital assets are being viewed not as speculative gambles, but as legitimate components of a modern corporate treasury and growth strategy. This could pave the way for more traditional firms to follow suit, bringing significant new capital and credibility into the ecosystem. Navigating the Challenges of a Corporate SOL Investment While the opportunity is immense, this strategic SOL investment does not come without its hurdles. Mangoceuticals must navigate a complex landscape of regulatory uncertainty, market volatility inherent to cryptocurrencies, and the technical complexities of secure asset custody. Their partnership with an experienced firm like Cube Group is a crucial step in mitigating these risks. Furthermore, they will need to maintain transparent communication with shareholders about the performance and rationale behind this digital asset allocation. Conclusion: A Watershed Moment for Solana and Crypto Mangoceuticals’ planned $100 million SOL investment is more than just a headline; it’s a watershed moment. It represents a maturation point where sophisticated institutional capital is strategically allocating to specific blockchain ecosystems based on their utility and potential. This move validates Solana’s technology and could accelerate the trend of tokenizing real-world assets and integrating crypto into traditional business finance. The future of corporate treasury management is being rewritten, one digital asset at a time. Frequently Asked Questions (FAQs) Q1: What exactly is Mangoceuticals investing in? A1: Mangoceuticals is primarily investing in SOL, the native cryptocurrency of the Solana blockchain, with plans to allocate up to $100 million through its new Digital Asset Treasury subsidiary. Q2: Why did a healthcare company decide to invest in Solana? A2: The company is likely diversifying its corporate treasury and seeking growth opportunities in the digital asset space, viewing blockchain technology and high-performance networks like Solana as a strategic financial frontier. Q3: Who is managing this investment? A3: The asset custody and strategy are being overseen by Cube Group, a firm led by a former core developer from the Solana project, ensuring expert management. Q4: What other crypto activities is Mangoceuticals planning? A4: Beyond the SOL purchase, the company plans to explore Real World Asset (RWA) tokenization, engage in staking and node operations on the Solana network, and adopt stablecoins for payments. Q5: Is this a sign of more institutional adoption to come? A5: Yes, a Nasdaq-listed company making such a public commitment often signals to other institutional players that allocating to cryptocurrencies is becoming a mainstream corporate finance strategy. Q6: What are the main risks for Mangoceuticals? A6: Key risks include the volatility of crypto markets, evolving regulatory landscapes, and the technical challenges of securely managing a large digital asset treasury. Share This Insight Was this analysis of a major institutional SOL investment helpful? If you found this deep dive into Mangoceuticals’ crypto strategy valuable, share it with your network on social media. Help others understand this pivotal moment in the convergence of traditional finance and blockchain technology. To learn more about the latest trends in institutional cryptocurrency adoption, explore our article on key developments shaping Solana and the broader digital asset market’s future trajectory. This post Strategic SOL Investment: Nasdaq Giant Mangoceuticals Allocates $100M to Solana Treasury first appeared on BitcoinWorld .
BoJ to Continue Gradual Rate Hikes Next Year, Likely After June as Wage Growth Hinges on Spring Negotiations
The Bitcoin NVT Golden Cross is signaling a partial recovery from deep undervaluation, as the metric rises from -0.58 to -0.32, indicating easing caution in pricing relative to network activity. This suggests selective accumulation amid softening institutional demand, with Bitcoin's price stabilizing near key support levels. Bitcoin NVT Golden Cross rises from -0.58 to -0.32, [...]